TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) has issued an announcement.
Hansoh Pharmaceutical Group Company Limited has announced a board meeting scheduled for August 18, 2025, to consider and approve the interim results for the first half of the year and discuss the recommendation of an interim dividend. This meeting is significant as it may impact the company’s financial strategies and stakeholder interests.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$34.83 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.
Average Trading Volume: 11,695,934
Technical Sentiment Signal: Buy
Current Market Cap: HK$207.6B
Learn more about 3692 stock on TipRanks’ Stock Analysis page.